Stocks That Hit 52-Week Lows On Friday
During Friday's morning session, 234 stocks hit new 52-week lows.
Celcuity Plans To Start Pivotal Gedatolisib Trial In Breast Cancer In 1H 2022
Celcuity Inc (NASDAQ:CELC) concluded two formal meetings with the FDA to obtain their feedback on the gedatolisib Phase 3 trial in…
Recap: Celcuity Q4 Earnings
Celcuity (NASDAQ:CELC) reported its Q4 earnings results on Wednesday, March 23, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Celcuity beat estimated earnings by 2.63%, reporting an EPS of $-0.37 versus an estimate of $-0.38.
Earnings Scheduled For March 23, 2022
Companies Reporting Before The Bell
• AYRO (NASDAQ:AYRO) is expected to report earnings for its fourth quarter.
Preview: Celcuity’s Earnings
Celcuity (NASDAQ:CELC) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement.
Analysts estimate that Celcuity will report an earnings per share (EPS) of $-0.38.
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment during the week.
